Premature adrenarche: Novel lessons from early onset androgen excess

European Journal of Endocrinology

Volumn 165, Issue 2, 2011, Pages 189-207

  Idkowiak, Jan ^a   Lavery, Gareth G ^a   Dhir, Vivek ^a   Barrett, Timothy G ^a   Stewart, Paul M ^a   Krone, Nils ^a   Arlt, Wiebke ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA(OR 20BETA) HYDROXYSTEROID DEHYDROGENASE; PRASTERONE; PRASTERONE SULFATE; ANDROGEN; GONADORELIN DERIVATIVE;

ADRENAL CORTEX; ADRENAL DISEASE; ADRENAL INSUFFICIENCY; ANDROGEN RELEASE; APPARENT CORTISONE REDUCTASE DEFICIENCY; APPARENT PRASTERONE SULFOTRANSFERASE DEFICIENCY; BREAST DEVELOPMENT; DEVELOPMENTAL DISORDER; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; GENE MUTATION; HORMONE SUBSTITUTION; HUMAN; HYPERANDROGENISM; INBORN ERROR OF STEROID METABOLISM; INSULIN RESISTANCE; LOW BIRTH WEIGHT; METABOLIC SYNDROME X; OVARY POLYCYSTIC DISEASE; PRECOCIOUS PUBERTY; PREMATURE ADRENARCHE; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STEROIDOGENESIS; TESTIS DEVELOPMENT; ADRENARCHE; ADULT; ANIMAL; BIOLOGICAL MODEL; BLOOD; FEMALE; MALE; ONSET AGE; OSMOLARITY; PHYSIOLOGY; TIME; CLINICAL FEATURE; DISEASE COURSE; DISORDERS OF HORMONE METABOLISM; INCIDENCE; MONOGENIC DISORDER; NONHUMAN; PREVALENCE;

ADRENARCHE; ADULT; AGE OF ONSET; ANDROGENS; ANIMALS; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; OSMOLAR CONCENTRATION; PUBERTY, PRECOCIOUS; TIME FACTORS;

EID: 79960188174     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0223     Document Type: Review

References (158)

1. Cutler GB Jr, Glenn M, Bush M, Hodgen GD, Graham CE & Loriaux DL. Adrenarche: a survey of rodents, domestic animals, and primates. Endocrinology 1978 103 2112-2118. (doi:10.1210/endo-103-6-2112)
2. Smail PJ, Faiman C, Hobson WC, Fuller GB & Winter JS. Further studies on adrenarche in nonhuman primates. Endocrinology 1982 111 844-848. (doi:10.1210/endo-111-3-844)
3. Conley AJ, Pattison JC & Bird IM. Variations in adrenal androgen production among (nonhuman) primates. Seminars in Reproductive Medicine 2004 22 311-326. (doi:10.1055/s-2004-861548)
4. Arlt W, Martens J, Song M, Wang J, Auchus R & Miller W. Molecular evolution of adrenarche: structural and functional analysis of p450c17 from four primate species. Endocrinology 2002 143 4665-4672. (doi:10.1210/en.2002-220456)
5. Auchus R & Rainey W. Adrenarche - physiology, biochemistry and human disease. Clinical Endocrinology 2004 60 288-296. (doi:10.1046/j.1365-2265.2003. 01858.x)
6. Albright F, Smith PH & Fraser R. A syndrome characterized by primary ovarian insufficiency and decreased stature: a report of 11 cases with digression on hormonal control of axillary and pubic hair. American Journal of the Medical Sciences 1942 204 625. (doi:10.1097/00000441-194211000-00001)
7. Talbot NB, Butler AM, Berman RA, Rodriguez PM & Maclachlan EA. Excretion of 17-keto steroids by normal and abnormal children. American Journal of Diseases of Children 1943 65 364-375.
8. Albright F. Osteoporosis. Annals of Internal Medicine 1947 27 861-882.
9. Silverman SH, Migeon C, Rosemberg E & Wilkins L. Precocious growth of sexual hair without other secondary sexual development; premature pubarche, a constitutional variation of adolescence. Pediatrics 1952 10 426-432.
10. Hochberg Z. Juvenility in the context of life history theory. Archives of Disease in Childhood 2008 93 534-539. (doi:10.1136/adc.2008.137570)
11. Hochberg Z. Evo-devo of child growth III: premature juvenility as an evolutionary trade-off. Hormone Research in Pediatrics 2010 73 430-437. (doi:10.1159/000282109)
12. Campbell B. Adrenarche in comparative perspective. American Journal of Human Biology 2011 23 44-52. (doi:10.1002/ajhb.21111)
13. de Peretti E & Forest MG. Unconjugated dehydroepiandrosterone plasma levels in normal subjects from birth to adolescence in human: the use of a sensitive radioimmunoassay. Journal of Clinical Endocrinology and Metabolism 1976 43 982-991. (doi:10.1210/jcem-43-5-982)
14. de Peretti E & Forest MG. Pattern of plasma dehydroepiandrosterone sulfate levels in humans from birth to adulthood: evidence for testicular production. Journal of Clinical Endocrinology and Metabolism 1978 47 572-577. (doi:10.1210/jcem-47-3-572)
15. Sizonenko PC & Paunier L. Hormonal changes in puberty III: correlation of plasma dehydroepiandrosterone, testosterone, FSH, and LH with stages of puberty and bone age in normal boys and girls and in patients with Addison's disease or hypogonadism or with premature or late adrenarche. Journal of Clinical Endocrinology and Metabolism 1975 41 894-904. (doi:10.1210/jcem-41- 5-894)
16. Korth-Schutz S, Levine LS & New MI. Serum androgens in normal prepubertal and pubertal children and in children with precocious adrenarche. Journal of Clinical Endocrinology and Metabolism 1976 42 117-124. (doi:10.1210/jcem-42-1-117)
17. Remer T, Boye KR, Hartmann MF & Wudy SA. Urinary markers of adrenarche: reference values in healthy subjects, aged 3-18 years. Journal of Clinical Endocrinology and Metabolism 2005 90 2015-2021. (doi:10.1210/jc.2004- 1571)
18. Marshall WA & Tanner JM. Variations in pattern of pubertal changes in girls. Archives of Disease in Childhood 1969 44 291-303. (doi:10.1136/adc.44. 235.291)
19. Marshall WA & Tanner JM. Variations in the pattern of pubertal changes in boys. Archives of Disease in Childhood 1970 45 13-23. (doi:10.1136/adc.45.239.13)
20. Arlt W, Callies F, van Vlijmen J, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte H & Allolio B. Dehydroepiandrosterone replacement in women with adrenal insufficiency. New England Journal of Medicine 1999 341 1013-1020. (doi:10.1056/NEJM199909303411401)
21. Binder G, Weber S, Ehrismann M, Zaiser N, Meisner C, Ranke MB, Maier L, Wudy SA, Hartmann MF, Heinrich U, Bettendorf M, Doerr HG, Pfaeffle RW & Keller E. Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial. Journal of Clinical Endocrinology and Metabolism 2009 94 1182-1190. (doi:10.1210/jc.2008-1982)
22. Remer T, Manz F, Hartmann MF, Schoenau E & Wudy SA. Prepubertal healthy children's urinary androstenediol predicts diaphyseal bone strength in late puberty. Journal of Clinical Endocrinology and Metabolism 2009 94 575-578. (doi:10.1210/jc.2008-1375)
23. Voutilainen R, Perheentupa J & Apter D. Benign premature adrenarche: clinical features and serum steroid levels. Acta Paediatrica Scandinavica 1983 72 707-711. (doi:10.1111/j.1651-2227.1983.tb09798.x)
24. Sopher AB, Jean AM, Zwany SK, Winston DM, Pomeranz CB, Bell JJ, McMahon DJ, Hassoun A, Fennoy I & Oberfield SE. Bone age advancement in prepubertal children with obesity and premature adrenarche: possible potentiating factors. Obesity 2011 19 1259-1264. (doi:10.1038/oby.2010.305)
25. Sklar CA, Kaplan SL & Grumbach MM. Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. Journal of Clinical Endocrinology and Metabolism 1980 51 548-556. (doi:10.1210/jcem-51-3-548)
26. Counts DR, Pescovitz OH, Barnes KM, Hench KD, Chrousos GP, Sherins RJ, Comite F, Loriaux DL & Cutler GB Jr. Dissociation of adrenarche and gonadarche in precocious puberty and in isolated hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 1987 64 1174-1178. (doi:10.1210/jcem-64-6-1174)
27. Martin DD, Schweizer R, Schwarze CP, Elmlinger MW, Ranke MB & Binder G. The early dehydroepiandrosterone sulfate rise of adrenarche and the delay of pubarche indicate primary ovarian failure in Turner syndrome. Journal of Clinical Endocrinology and Metabolism 2004 89 1164-1168. (doi:10.1210/jc.2003- 031700)
28. Benetti-Pinto CL, Bedone AJ & Magna LA. Evaluation of serum androgen levels in women with premature ovarian failure. Fertility and Sterility 2005 83 508-510. (doi:10.1016/j.fertnstert.2004.09.015)
29. Kalantaridou SN, Calis KA, Mazer NA, Godoy H & Nelson LM. A pilot study of an investigational testosterone transdermal patch system in young women with spontaneous premature ovarian failure. Journal of Clinical Endocrinology and Metabolism 2005 90 6549-6552. (doi:10.1210/jc.2005-0692)
30. Arlt W. Androgen therapy in women. European Journal of Endocrinology 2006 154 1-11. (doi:10.1530/eje.1.02062)
31. Wierman ME, Beardsworth DE, Crawford JD, Crigler JF Jr, Mansfield MJ, Bode HH, Boepple PA, Kushner DC & Crowley WF Jr. Adrenarche and skeletal maturation during luteinizing hormone releasing hormone analogue suppression of gonadarche. Journal of Clinical Investigation 1986 77 121-126. (doi:10.1172/JCI112265)
32. Palmert MR, Hayden DL, Mansfield MJ, Crigler JF Jr, Crowley WF Jr, Chandler DW & Boepple PA. The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process. Journal of Clinical Endocrinology and Metabolism 2001 86 4536-4542. (doi:10.1210/jc.86.9.4536)
33. Parker LN & Odell WD. Control of adrenal androgen secretion. Endocrine Reviews 1980 1 392-410. (doi:10.1210/edrv-1-4-392)
34. Mellon SH, Shively JE & Miller WL. Human proopiomelanocortin-(79-96), a proposed androgen stimulatory hormone, does not affect steroidogenesis in cultured human fetal adrenal cells. Journal of Clinical Endocrinology and Metabolism 1991 72 19-22. (doi:10.1210/jcem-72-1-19)
35. Weber A, Clark AJ, Perry LA, Honour JW & Savage MO. Diminished adrenal androgen secretion in familial glucocorticoid deficiency implicates a significant role for ACTH in the induction of adrenarche. Clinical Endocrinology 1997 46 431-437. (doi:10.1046/j.1365-2265.1997.1580969.x)
36. Taha D, Mullis PE, Ibáñez L & De Zegher F. Absent or delayed adrenarche in Pit-1/POU1F1 deficiency. Hormone Research 2005 64 175-179. (doi:10.1159/000088793)
37. Lappalainen S, Utriainen P, Kuulasmaa T, Voutilainen R & Jääskeläinen J. ACTH receptor promoter polymorphism associates with severity of premature adrenarche and modulates hypothalamo-pituitary- adrenal axis in children. Pediatric Research 2008 63 410-414. (doi:10.1203/PDR.0b013e3181659c14)
38. Lappalainen S, Utriainen P, Kuulasmaa T, Voutilainen R & Jääskeläinen J. Androgen receptor gene CAG repeat polymorphism and X-chromosome inactivation in children with premature adrenarche. Journal of Clinical Endocrinology and Metabolism 2008 93 1304-1309. (doi:10.1210/jc.2007- 2707)
39. Lappalainen S, Voutilainen R, Utriainen P, Laakso M & Jääskeläinen J. Genetic variation of FTO and TCF7L2 in premature adrenarche. Metabolism: Clinical and Experimental 2009 58 1263-1269. (doi:10.1016/j.metabol.2009.03.025)
40. Remer T, Shi L, Buyken AE, Maser-Gluth C, Hartmann MF & Wudy SA. Prepubertal adrenarchal androgens and animal protein intake independently and differentially influence pubertal timing. Journal of Clinical Endocrinology and Metabolism 2010 95 3002-3009. (doi:10.1210/jc.2009-2583)
41. Remer T, Boye KR, Hartmann M, Neu CM, Schoenau E, Manz F & Wudy SA. Adrenarche and bone modeling and remodeling at the proximal radius: weak androgens make stronger cortical bone in healthy children. Journal of Bone and Mineral Research 2003 18 1539-1546. (doi:10.1359/jbmr.2003.18.8.1539)
42. l'Allemand D, Schmidt S, Rousson V, Brabant G, Gasser T & Gruters A. Associations between body mass, leptin, IGF-I and circulating adrenal androgens in children with obesity and premature adrenarche. European Journal of Endocrinology 2002 146 537-543. (doi:10.1530/eje.0.1460537)
43. Denzer C, Weibel A, Muche R, Karges B, Sorgo W & Wabitsch M. Pubertal development in obese children and adolescents. International Journal of Obesity 2007 31 1509-1519. (doi:10.1038/sj.ijo.0803691)
44. Kaplowitz PB, Cockrell JL & Young RB. Premature adrenarche. Clinical and diagnostic features. Clinical Pediatrics 1986 25 28-34. (doi:10.1177/ 000992288602500105)
45. Ibanez L, Virdis R, Potau N, Zampolli M, Ghizzoni L, Albisu MA, Carrascosa A, Bernasconi S & Vicens-Calvet E. Natural history of premature pubarche: an auxological study. Journal of Clinical Endocrinology and Metabolism 1992 74 254-257. (doi:10.1210/jc.74.2.254)
46. Pere A, Perheentupa J, Peter M & Voutilainen R. Follow up of growth and steroids in premature adrenarche. European Journal of Pediatrics 1995 154 346-352. (doi:10.1007/BF02072100)
47. Ghizzoni L & Milani S. The natural history of premature adrenarche. Journal of Pediatric Endocrinology & Metabolism 2000 13 (Supplement 5) 1247-1251.
48. Accetta SG, Di Domênico K, Ritter CG, Ritter AT, Capp E & Spritzer PM. Anthropometric and endocrine features in girls with isolated premature pubarche or non-classical congenital adrenal hyperplasia. Journal of Pediatric Endocrinology & Metabolism 2004 17 767-773. (doi:10.1515/JPEM. 2004.17.5.767)
49. Utriainen P, Jaaskelainen J, Saarinen A, Vanninen E, Makitie O & Voutilainen R. Body composition and bone mineral density in children with premature adrenarche and the association of LRP5 gene polymorphisms with bone mineral density. Journal of Clinical Endocrinology and Metabolism 2009 94 4144-4151. (doi:10.1210/jc.2009-0315)
50. Banerjee S, Raghavan S, Wasserman EJ, Linder BL, Saenger P & DiMartino-Nardi J. Hormonal findings in African-American and Caribbean Hispanic girls with premature adrenarche: implications for polycystic ovarian syndrome. Pediatrics 1998 102 E36. (doi:10.1542/peds.102.3.e36)
51. Utriainen P, Voutilainen R & Jääskeläinen J. Continuum of phenotypes and sympathoadrenal function in premature adrenarche. European Journal of Endocrinology 2009 160 657-665. (doi:10.1530/EJE-08-0367)
52. Rosenfield RL. Clinical review: identifying children at risk for polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2007 92 787-796. (doi:10.1210/jc.2006-2012)
53. Likitmaskul S, Cowell CT, Donaghue K, Kreutzmann DJ, Howard NJ, Blades B & Silink M. 'Exaggerated adrenarche' in children presenting with premature adrenarche. Clinical Endocrinology 1995 42 265-272. (doi:10.1111/j.1365-2265. 1995.tb01874.x)
54. Remer T, Maser-Gluth C, Boye KR, Hartmann MF, Heinze E & Wudy SA. Exaggerated adrenarche and altered cortisol metabolism in type 1 diabetic children. Steroids 2006 71 591-598. (doi:10.1016/j.steroids.2006.02.005)
55. Paterson WF, Ahmed SF, Bath L, Donaldson MD, Fleming R, Greene SA, Hunter I, Kelnar CJ, Mayo A, Schulga JS, Shapiro D, Smail PJ & Wallace AM. Exaggerated adrenarche in a cohort of Scottish children: clinical features and biochemistry. Clinical Endocrinology 2009 72 496-501. (doi:10.1111/j.1365-2265. 2009.03739.x)
56. Utriainen P, Jääskeläinen J, Romppanen J & Voutilainen R. Childhood metabolic syndrome and its components in premature adrenarche. Journal of Clinical Endocrinology and Metabolism 2007 92 4282-4285. (doi:10.1210/jc.2006-2412)
57. Zukauskaite S, Lasiene D, Lasas L, Urbonaite B & Hindmarsh P. Onset of breast and pubic hair development in 1231 preadolescent Lithuanian schoolgirls. Archives of Disease in Childhood 2005 90 932-936. (doi:10.1136/adc.2004.057612)
58. Rosenfield RL, Lipton RB & Drum ML. Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index. Pediatrics 2009 123 84-88. (doi:10.1542/peds.2008-0146)
59. Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG & Hasemeier CM. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics 1997 99 505-512. (doi:10.1542/peds.99.4.505)
60. Rosenfield RL. Normal and almost normal precocious variations in pubertal development. Premature pubarche and premature thelarche revisited. Hormone Research 1994 41 (Supplement 2) 7-13. (doi:10.1159/000183950)
61. Armengaud JB, Charkaluk ML, Trivin C, Tardy V, Breart G, Brauner R & Chalumeau M. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche. Journal of Clinical Endocrinology and Metabolism 2009 94 2835-2840. (doi:10.1210/jc.2009-0314)
62. Dacou-Voutetakis C & Dracopoulou M. High incidence of molecular defects of the CYP21 gene in patients with premature adrenarche. Journal of Clinical Endocrinology and Metabolism 1999 84 1570-1574. (doi:10.1210/jc.84.5. 1570)
63. Balducci R, Boscherini B, Mangiantini A, Morellini M & Toscano V. Isolated precocious pubarche: an approach. Journal of Clinical Endocrinology and Metabolism 1994 79 582-589. (doi:10.1210/jc.79.2.582)
64. del Balzo P, Borrelli P, Cambiaso P, Danielli E & Cappa M. Adrenal steroidogenic defects in children with precocious pubarche. Hormone Research 1992 37 180-184. (doi:10.1159/000182306)
65. Temeck JW, Pang SY, Nelson C & New MI. Genetic defects of steroidogenesis in premature pubarche. Journal of Clinical Endocrinology and Metabolism 1987 64 609-617. (doi:10.1210/jcem-64-3-609)
66. Pescovitz OH, Comite F, Cassorla F, Dwyer AJ, Poth MA, Sperling MA, Hench K, McNemar A, Skerda M, Loriaux DL & Cutler GB Jr. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog. Journal of Clinical Endocrinology and Metabolism 1984 58 857-861. (doi:10.1210/jcem-58-5-857)
67. Boepple PA, Mansfield MJ, Wierman ME, Rudlin CR, Bode HH, Crigler JF Jr, Crawford JD & Crowley WF Jr. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty. Endocrine Reviews 1986 7 24-33. (doi:10.1210/edrv-7-1-24)
68. Comite F, Cassorla F, Barnes KM, Hench KD, Dwyer A, Skerda MC, Loriaux DL, Cutler GB Jr & Pescovitz OH. Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height. Journal of the American Medical Association 1986 255 2613-2616. (doi:10.1001/jama.255.19.2613)
69. Ibáñez L, Díaz R, López-Bermejo A & Marcos MV. Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism. Reviews in Endocrine & Metabolic Disorders 2009 10 63-76. (doi:10.1007/s11154-008-9096-y)
70. Ibáñez L, Dimartino-Nardi J, Potau N & Saenger P. Premature adrenarche - normal variant or forerunner of adult disease? Endocrine Reviews 2000 21 671-696. (doi:10.1210/er.21.6.671)
71. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS & Ghazzi MN. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2006 91 48-53. (doi:10.1210/jc.2005-1329)
72. Ibanez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinye M, Carrascosa A & Vicens-Calvet E. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 1993 76 1599-1603. (doi:10.1210/jc.76.6.1599)
73. Ibanez L, de Zegher F & Potau N. Anovulation after precocious pubarche: early markers and time course in adolescence. Journal of Clinical Endocrinology and Metabolism 1999 84 2691-2695. (doi:10.1210/jc.84.8.2691)
74. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S & Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology and Metabolism 2000 85 2434-2438. (doi:10.1210/jc.85.7.2434)
75. Oppenheimer E, Linder B & DiMartino-Nardi J. Decreased insulin sensitivity in prepubertal girls with premature adrenarche and acanthosis nigricans. Journal of Clinical Endocrinology and Metabolism 1995 80 614-618. (doi:10.1210/jc.80.2.614)
76. Ibanez L, Potau N, Zampolli M, Prat N, Virdis R, Vicens-Calvet E & Carrascosa A. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 1996 81 1237-1243. (doi:10.1210/jc.81.3.1237)
77. Ibanez L, Potau N, Zampolli M, Rique S, Saenger P & Carrascosa A. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. Journal of Clinical Endocrinology and Metabolism 1997 82 2283-2288. (doi:10.1210/jc.82.7.2283)
78. Ibanez L, Potau N, Chacon P, Pascual C & Carrascosa A. Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 1998 41 1057-1063. (doi:10.1007/ s001250051030)
79. Ibanez L, Aulesa C, Potau N, Ong K, Dunger DB & de Zegher F. Plasminogen activator inhibitor-1 in girls with precocious pubarche: a premenarcheal marker for polycystic ovary syndrome? Pediatric Research 2002 51 244-248. (doi:10.1203/00006450-200202000-00019)
80. Potau N, Williams R, Ong K, Sanchez-Ufarte C, de Zegher F, Ibanez L & Dunger D. Fasting insulin sensitivity and postoral glucose hyperinsulinaemia related to cardiovascular risk factors in adolescents with precocious pubarche. Clinical Endocrinology 2003 59 756-762. (doi:10.1046/j.1365-2265.2003.01919.x)
81. Potau N, Ibanez L, Rique S, Sanchez-Ufarte C & de Zegher F. Pronounced adrenarche and precocious pubarche in boys. Hormone Research 1999 51 238-241. (doi:10.1159/000023377)
82. Denburg MR, Silfen ME, Manibo AM, Chin D, Levine LS, Ferin M, McMahon DJ, Go C & Oberfield SE. Insulin sensitivity and the insulin-like growth factor system in prepubertal boys with premature adrenarche. Journal of Clinical Endocrinology and Metabolism 2002 87 5604-5609. (doi:10.1210/jc.2002-020896)
83. Vuguin P, Linder B, Rosenfeld RG, Saenger P & DiMartino-Nardi J. The roles of insulin sensitivity, insulin-like growth factor I (IGF-I), and IGF-binding protein-1 and -3 in the hyperandrogenism of African-American and Caribbean Hispanic girls with premature adrenarche. Journal of Clinical Endocrinology and Metabolism 1999 84 2037-2042. (doi:10.1210/jc.84.6.2037)
84. Wild RA, Rizzo M, Clifton S & Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertility and Sterility 2011 95 1073-9.e1-1073-9.e11. (doi:10.1016/j.fertnstert.2010.12.027)
85. Ibanez L, Ong K, de Zegher F, Marcos MV, del Rio L & Dunger DB. Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche. Clinical Endocrinology 2003 58 372-379. (doi:10.1046/j.1365-2265. 2003.01728.x)
86. Güven A, Cinaz P & Bideci A. Is premature adrenarche a risk factor for atherogenesis? Pediatrics International 2005 47 20-25. (doi:10.1111/j.1442-200x.2004.02006.x)
87. Teixeira RJ, Ginzbarg D, Rodrigues Freitas J, Fucks G, Silva CM & Bordallo MA. Serum leptin levels in premature pubarche and prepubertal girls with and without obesity. Journal of Pediatric Endocrinology & Metabolism 2004 17 1393-1398. (doi:10.1515/JPEM.2004.17.10.1393)
88. Andiran N & Yordam N. Lipoprotein(a) levels in girls with premature adrenarche. Journal of Paediatrics and Child Health 2008 44 138-142. (doi:10.1111/j.1440-1754.2007.01210.x)
89. Livadas S, Dracopoulou M, Vasileiadi K, Lazaropoulou C, Magiakou MA, Xekouki P, Voutetakis A, Kanaka-Gantenbein C, Papassotiriou I, Stefanadis C, Chrousos GP & Dacou-Voutetakis C. Elevated coagulation and inflammatory markers in adolescents with a history of premature adrenarche. Metabolism 2009 58 576-581. (doi:10.1016/j.metabol.2008.12.002)
90. Larque E, Gil-Campos M, Villada I, Ramirez-Tortosa MC, Canete R & Gil A. Postprandial plasma adiponectin response is reduced in prepubertal premature pubarche girls. Metabolism 2010 59 1319-1326. (doi:10.1016/j.metabol.2009.12. 009)
91. Mathieu P, Lemieux I & Despres JP. Obesity, inflammation, and cardiovascular risk. Clinical Pharmacology and Therapeutics 2010 87 407-416. (doi:10.1038/clpt.2009.311)
92. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006 55 1537-1545. (doi:10.2337/db06-0263)
93. Alessi MC, Poggi M & Juhan-Vague I. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Current Opinion in Lipidology 2007 18 240-245. (doi:10.1097/MOL.0b013e32814e6d29)
94. Escobar-Morreale HF, Luque-Ramirez M & Gonzalez F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertility and Sterility 2011 95 1048-58.e1-1048-58.e2.
95. Mathew RP, Byrne DW, Linton MF, Vaughan DE, Fazio S & Russell WE. Evidence of metabolic syndrome in lean children with premature pubarche at diagnosis. Metabolism 2008 57 733-740. (doi:10.1016/j.metabol.2008.01.010)
96. Ibáñez L, Potau N, Zampolli M, Street ME & Carrascosa A. Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: evidence from gonadotropin-releasing hormone agonist testing. Fertility and Sterility 1997 67 849-855. (doi:10.1016/S0015-0282(97)81396-9)
97. Ibanez L, Potau N, Marcos MV & De Zegher F. Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche. Clinical Endocrinology 2000 53 523-527. (doi:10.1046/j.1365-2265.2000.01133.x)
98. Mathew RP, Najjar JL, Lorenz RA, Mayes DE & Russell WE. Premature pubarche in girls is associated with functional adrenal but not ovarian hyperandrogenism. Journal of Pediatrics 2002 141 91-98. (doi:10.1067/mpd.2002. 125492)
99. Broekmans FJ, Visser JA, Laven JS, Broer SL, Themmen AP & Fauser BC. Anti-Mullerian hormone and ovarian dysfunction. Trends in Endocrinology and Metabolism 2008 19 340-347. (doi:10.1016/j.tem.2008.08.002)
100. Utriainen P, Jaaskelainen J & Voutilainen R. Serum anti-Mullerian hormone concentrations in prepubertal girls with and without premature adrenarche: the influence of body mass index. Hormone Research in Pediatrics 2010 74 207-211. (doi:10.1159/000282113)
101. Mesiano S, Katz SL, Lee JY & Jaffe RB. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation. Journal of Clinical Endocrinology and Metabolism 1997 82 1390-1396. (doi:10.1210/jc.82.5.1390)
102. l'Allemand D, Penhoat A, Lebrethon MC, Ardevol R, Baehr V, Oelkers W & Saez JM. Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells. Journal of Clinical Endocrinology and Metabolism 1996 81 3892-3897. (doi:10.1210/jc.81.11. 3892)
103. Silfen ME, Manibo AM, Ferin M, McMahon DJ, Levine LS & Oberfield SE. Elevated free IGF-I levels in prepubertal Hispanic girls with premature adrenarche: relationship with hyperandrogenism and insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 2002 87 398-403. (doi:10.1210/jc.87.1. 398)
104. Utriainen P, Voutilainen R & Jaaskelainen J. Girls with premature adrenarche have accelerated early childhood growth. Journal of Pediatrics 2009 154 882-887. (doi:10.1016/j.jpeds.2008.12.038)
105. Kelly CJ, Stenton SR & Lashen H. Insulin-like growth factor binding protein-1 in PCOS: a systematic review and meta-analysis. Human Reproduction Update 2011 17 4-16. (doi:10.1093/humupd/dmq027)
106. Barker DJ, Winter PD, Osmond C, Margetts B & Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 1989 2 577-580. (doi:10.1016/S0140-6736(89)90710-1)
107. Barker DJ & Osmond C. Low birth weight and hypertension. BMJ 1988 297 134-135. (doi:10.1136/bmj.297.6641.134-b)
108. Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD & Shaheen SO. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 1991 303 671-675. (doi:10.1136/bmj.303.6804.671)
109. Hales CN & Barker DJ. The thrifty phenotype hypothesis. British Medical Bulletin 2001 60 5-20. (doi:10.1093/bmb/60.1.5)
110. Ibáñez L, Potau N, Francois I & de Zegher F. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. Journal of Clinical Endocrinology and Metabolism 1998 83 3558-3562. (doi:10.1210/jc.83.10.3558)
111. Ibanez L, Potau N & de Zegher F. Precocious pubarche, dyslipidemia, and low IGF binding protein-1 in girls: relation to reduced prenatal growth. Pediatric Research 1999 46 320-322. (doi:10.1203/00006450-199909000-00012)
112. Ibáñez L, Potau N, Marcos MV & de Zegher F. Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. Journal of Clinical Endocrinology and Metabolism 1999 84 4739-4741. (doi:10.1210/jc.84.12.4739)
113. Ibanez L, Ong K, Dunger DB & de Zegher F. Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children. Journal of Clinical Endocrinology and Metabolism 2006 91 2153-2158. (doi:10.1210/jc.2005-2778)
114. Ibanez L, Lopez-Bermejo A, Suarez L, Marcos MV, Diaz M & de Zegher F. Visceral adiposity without overweight in children born small for gestational age. Journal of Clinical Endocrinology and Metabolism 2008 93 2079-2083. (doi:10.1210/jc.2007-2850)
115. Ibanez L, Lopez-Bermejo A, Diaz M, Suarez L & de Zegher F. Low-birth weight children develop lower sex hormone binding globulin and higher dehydroepiandrosterone sulfate levels and aggravate their visceral adiposity and hypoadiponectinemia between six and eight years of age. Journal of Clinical Endocrinology and Metabolism 2009 94 3696-3699. (doi:10.1210/jc.2009-0789)
116. Meas T, Chevenne D, Thibaud E, Leger J, Cabrol S, Czernichow P & Levy-Marchal C. Endocrine consequences of premature pubarche in post-pubertal Caucasian girls. Clinical Endocrinology 2002 57 101-106. (doi:10.1046/j.1365- 2265.2002.01579.x)
117. Cresswell JL, Barker DJ, Osmond C, Egger P, Phillips DI & Fraser RB. Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet 1997 350 1131-1135. (doi:10.1016/S0140-6736(97)06062-5)
118. Laitinen J, Taponen S, Martikainen H, Pouta A, Millwood I, Hartikainen AL, Ruokonen A, Sovio U, McCarthy MI, Franks S & Jarvelin MR. Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms. International Journal of Obesity and Related Metabolic Disorders 2003 27 710-715. (doi:10.1038/sj.ijo.0802301)
119. Ghirri P, Bernardini M, Vuerich M, Cuttano AM, Coccoli L, Merusi I, Ciulli C, D'Accavio L, Bottone U & Boldrini A. Adrenarche, pubertal development, age at menarche and final height of full-term, born small for gestational age (SGA) girls. Gynecological Endocrinology 2001 15 91-97. (doi:10.1080/gye.15.2.91.97)
120. Charkaluk ML, Trivin C & Brauner R. Premature pubarche as an indicator of how body weight influences the onset of adrenarche. European Journal of Pediatrics 2004 163 89-93. (doi:10.1007/s00431-003-1358-9)
121. Neville KA & Walker JL. Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity. Archives of Disease in Childhood 2005 90 258-261. (doi:10.1136/adc.2004.053959)
122. Ong KK, Potau N, Petry CJ, Jones R, Ness AR, Honour JW, De Zegher F, Ibáñez L, Dunger DB & Team ALSoPaCS. Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls. Journal of Clinical Endocrinology and Metabolism 2004 89 2647-2651. (doi:10.1210/jc.2003-031848)
123. Clark PM, Hindmarsh PC, Shiell AW, Law CM, Honour JW & Barker DJ. Size at birth and adrenocortical function in childhood. Clinical Endocrinology 1996 45 721-726. (doi:10.1046/j.1365-2265.1996.8560864.x)
124. Dhom G. The prepubertal and pubertal growth of the adrenal (adrenarche). Beiträge zur Pathologie 1973 150 357-377.
125. Hyatt PJ, Bhatt K & Tait JF. Steroid biosynthesis by zona fasciculata and zona reticularis cells purified from the mammalian adrenal cortex. Journal of Steroid Biochemistry 1983 19 953-959. (doi:10.1016/0022-4731(83)90039-0)
126. Endoh A, Kristiansen SB, Casson PR, Buster JE & Hornsby PJ. The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase. Journal of Clinical Endocrinology and Metabolism 1996 81 3558-3565. (doi:10.1210/jc.81.10.3558)
127. Suzuki T, Sasano H, Takeyama J, Kaneko C, Freije WA, Carr BR & Rainey WE. Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies. Clinical Endocrinology 2000 53 739-747. (doi:10.1046/j.1365-2265.2000.01144.x)
128. Miller WL. Androgen synthesis in adrenarche. Reviews in Endocrine & Metabolic Disorders 2009 10 3-17. (doi:10.1007/s11154-008-9102-4)
129. Hui XG, Akahira J, Suzuki T, Nio M, Nakamura Y, Suzuki H, Rainey WE & Sasano H. Development of the human adrenal zona reticularis: morphometric and immunohistochemical studies from birth to adolescence. Journal of Endocrinology 2009 203 241-252. (doi:10.1677/JOE-09-0127)
130. Auchus RJ, Lee TC & Miller WL. Cytochrome b5 augments the 17,20-lyase
131. Schiebinger RJ, Albertson BD, Cassorla FG, Bowyer DW, Geelhoed GW, Cutler GB Jr & Loriaux DL. The developmental changes in plasma adrenal androgens during infancy and adrenarche are associated with changing activities of adrenal microsomal 17-hydroxylase and 17,20-desmolase. Journal of Clinical Investigation 1981 67 1177-1182. (doi:10.1172/JCI110132)
132. Gell JS, Carr BR, Sasano H, Atkins B, Margraf L, Mason JI & Rainey WE. Adrenarche results from development of a 3beta-hydroxysteroid dehydrogenase-deficient adrenal reticularis. Journal of Clinical Endocrinology and Metabolism 1998 83 3695-3701. (doi:10.1210/jc.83.10.3695)
133. Dardis A, Saraco N, Rivarola MA & Belgorosky A. Decrease in the expression of the 3beta-hydroxysteroid dehydrogenase gene in human adrenal tissue during prepuberty and early puberty: implications for the mechanism of adrenarche. Pediatric Research 1999 45 384-388. (doi:10.1203/00006450-199903000- 00016)
134. Nakamura Y, Gang HX, Suzuki T, Sasano H & Rainey WE. Adrenal changes associated with adrenarche. Reviews in Endocrine & Metabolic Disorders 2009 10 19-26. (doi:10.1007/s11154-008-9092-2)
135. Lavery G, Walker E, Tiganescu A, Ride J, Shackleton C, Tomlinson J, Connell J, Ray D, Biason-Lauber A, Malunowicz E, Arlt W & Stewart P. Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency. Journal of Clinical Endocrinology and Metabolism 2008 93 3827-3832. (doi:10.1210/jc.2008-0743)
136. Noordam C, Dhir V, McNelis JC, Schlereth F, Hanley NA, Krone N, Smeitink JA, Smeets R, Sweep FCGJ, Claahsen-van der Grinten HL & Arlt W. Inactivating PAPSS2 mutations in a patient with premature pubarche. New England Journal of Medicine 2009 360 2310-2318. (doi:10.1056/NEJMoa0810489)
137. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M & Stewart PM. 11beta-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocrine Reviews 2004 25 831-866. (doi:10.1210/er.2003-0031)
138. Bujalska IJ, Draper N, Michailidou Z, Tomlinson JW, White PC, Chapman KE, Walker EA & Stewart PM. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1. Journal of Molecular Endocrinology 2005 34 675-684. (doi:10.1677/jme.1.01718)
139. White PC, Rogoff D, McMillan DR & Lavery GG. Hexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolism. Molecular and Cellular Endocrinology 2007 265-266 89-92. (doi:10.1016/j.mce.2006.12.022)
140. Lavery GG, Walker EA, Draper N, Jeyasuria P, Marcos J, Shackleton CH, Parker KL, White PC & Stewart PM. Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. Journal of Biological Chemistry 2006 281 6546-6551. (doi:10.1074/jbc.M512635200)
141. Jamieson A, Wallace AM, Andrew R, Nunez BS, Walker BR, Fraser R, White PC & Connell JM. Apparent cortisone reductase deficiency: a functional defect in 11beta-hydroxysteroid dehydrogenase type 1. Journal of Clinical Endocrinology and Metabolism 1999 84 3570-3574. (doi:10.1210/jc.84.10.3570)
142. Phillipov G, Palermo M & Shackleton CH. Apparent cortisone reductase deficiency: a unique form of hypercortisolism. Journal of Clinical Endocrinology and Metabolism 1996 81 3855-3860. (doi:10.1210/jc.81.11.3855)
143. Malunowicz EM, Romer TE, Urban M & Bossowski A. 11beta-Hydroxysteroid dehydrogenase type 1 deficiency ('apparent cortisone reductase deficiency') in a 6-year-old boy. Hormone Research 2003 59 205-210. (doi:10.1159/000069326)
144. Draper N, Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W, Lavery GG, Bedendo O, Ray DW, Laing I, Malunowicz E, White PC, Hewison M, Mason PJ, Connell JM, Shackleton CHL & Stewart PM. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nature Genetics 2003 34 434-439. (doi:10.1038/ng1214)
145. Krone N, Hughes BA, Lavery GG, Stewart PM, Arlt W & Shackleton CH. Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). Journal of Steroid Biochemistsry and Molecular Biology 2010 121 496-504. (doi:10.1016/j.jsbmb.2010. 04.010)
146. Hammer F, Subtil S, Lux P, Maser-Gluth C, Stewart PM, Allolio B & Arlt W. No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies. Journal of Clinical Endocrinology and Metabolism 2005 90 3600-3605. (doi:10.1210/jc.2004-2386)
147. Arlt W, Hammer F, Sanning P, Butcher S, Lord J, Allolio B, Annane D & Stewart P. Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock. Journal of Clinical Endocrinology and Metabolism 2006 91 2548-2554. (doi:10.1210/jc.2005-2258)
148. Fuda H, Shimizu C, Lee YC, Akita H & Strott CA. Characterization and expression of human bifunctional 3′-phosphoadenosine 5′- phosphosulphate synthase isoforms. Biochemical Journal 2002 365 497-504. (doi:10.1042/BJ20020044)
149. Faiyaz ul Haque M, King LM, Krakow D, Cantor RM, Rusiniak ME, Swank RT, Superti-Furga A, Haque S, Abbas H, Ahmad W, Ahmad M & Cohn DH. Mutations in orthologous genes in human spondyloepimetaphyseal dysplasia and the brachymorphic mouse. Nature Genetics 1998 20 157-162. (doi:10.1038/2458)
150. Strott CA. Sulfonation and molecular action. Endocrine Reviews 2002 23 703-732. (doi:10.1210/er.2001-0040)
151. Virdis R, Zampolli M, Ibanez L, Ghizzoni L, Street ME & Vicens-Calvet E. Il pubarca prematuro. Italian Journal of Pediatrics 1993 19 569-579.
152. Marui S, Castro M, Latronico AC, Elias LL, Arnhold IJ, Moreira AC & Mendonca BB. Mutations in the type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls. Clinical Endocrinology 2000 52 67-75. (doi:10.1046/j.1365-2265.2000.00873.x)
153. Mermejo LM, Elias LL, Marui S, Moreira AC, Mendonca BB & de Castro M. Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping. Journal of Clinical Endocrinology and Metabolism 2005 90 1287-1293. (doi:10.1210/jc.2004-1552)
154. Malchoff CD, Javier EC, Malchoff DM, Martin T, Rogol A, Brandon D, Loriaux DL & Reardon GE. Primary cortisol resistance presenting as isosexual precocity. Journal of Clinical Endocrinology and Metabolism 1990 70 503-507. (doi:10.1210/jcem-70-2-503)
155. Nader N, Bachrach BE, Hurt DE, Gajula S, Pittman A, Lescher R & Kino T. A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain. Journal of Clinical Endocrinology and Metabolism 2010 95 2281-2285. (doi:10.1210/jc.2009-2463)
156. Mason A, McNeill E, Wallace AM, Connell JM & Donaldson MD. Sexual precocity in a 4 year old boy. BMJ 2010 340 c2319. (doi:10.1136/bmj.c2319)
157. Silveira LG, Noel SD, Silveira-Neto AP, Abreu AP, Brito VN, Santos MG, Bianco SD, Kuohung W, Xu S, Gryngarten M, Escobar ME, Arnhold IJ, Mendonca BB, Kaiser UB & Latronico AC. Mutations of the KISS1 gene in disorders of puberty. Journal of Clinical Endocrinology and Metabolism 2010 95 2276-2280. (doi:10.1210/jc.2009-2421)
158. Teles MG, Bianco SD, Brito VN, Trarbach EB, Kuohung W, Xu S, Seminara SB, Mendonca BB, Kaiser UB & Latronico AC. A GPR54-activating mutation in a patient with central precocious puberty. New England Journal of Medicine 2008 358 709-715. (doi:10.1056/NEJMoa073443)